| The problem of Hispanic/Latinx under-representation in cancer clinical trials MR Espinoza-Gutarra, N Duma, P Aristizabal, B Segarra-Vazquez, ... JCO Oncology Practice 18 (5), 380-384, 2022 | 18 | 2022 |
| Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System CR Frei, H Le, D McHugh, K Ryan, X Jones, S Galley, K Franklin, CJ Baus, ... Leukemia & Lymphoma 62 (7), 1664-1673, 2021 | 11 | 2021 |
| CD123-targeted therapy in acute myeloid leukemia MR Espinoza-Gutarra, SD Green, JF Zeidner, H Konig Expert Review of Hematology 14 (6), 561-576, 2021 | 10 | 2021 |
| Immune-based therapeutic interventions for acute myeloid leukemia F Perna, MR Espinoza-Gutarra, G Bombaci, SS Farag, JE Schwartz Cancer Immunotherapies: Solid Tumors and Hematologic Malignancies, 225-254, 2022 | 8 | 2022 |
| A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic … J Zhang, J Luo, X Weng, Y Zhu, G Goyal, F Perna, M Espinoza-Gutarra, ... Annals of translational medicine 10 (12), 2022 | 5 | 2022 |
| Treatment patterns and outcomes of 1205 patients on novel agents in the US Veterans Health Administration (VHA) system: results from the largest retrospective EMR and chart … CR Frei, H Le, D McHugh, C Elesinmogun, S Galley, K Franklin, J Tavera, ... Blood 134, 795, 2019 | 5 | 2019 |
| Thrombotic events are unusual toxicities of chimeric antigen receptor T-cell therapies C Schorr, J Forindez, M Espinoza-Gutarra, R Mehta, N Grover, F Perna International Journal of Molecular Sciences 24 (9), 8349, 2023 | 4 | 2023 |
| Cancer‐related knowledge, beliefs, and behaviors among Hispanic/Latino residents of Indiana MR Espinoza‐Gutarra, SM Rawl, G Maupome, HA O'Leary, ... Cancer medicine 12 (6), 7470-7484, 2023 | 3 | 2023 |
| West Nile encephalitis, an unusual infection in a chronic lymphocytic leukemia patient MR Espinoza-Gutarra, SL Cervantez, Z Nooruddin Case Reports in Hematology 2018 (1), 3270348, 2018 | 2 | 2018 |
| Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia G Bourne, K Diebold, M Espinoza-Gutarra, Z Al-Kadhimi, K Bachiashvili, ... Leukemia Research 139, 107467, 2024 | 1 | 2024 |
| Low-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignancies K Parks, K Diebold, D Salzman, A Di Stasi, M Espinoza-Gutarra, R Bhatia, ... Blood 142, 7052, 2023 | 1 | 2023 |
| Immune reconstitution profile after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide M Espinoza-Gutarra, A Saad, O Jamy Stem Cell Investigation 10, 2023 | 1 | 2023 |
| Relationship between CD45 expression and outcomes in B lymphoblastic leukemia/lymphoma MR Espinoza-Gutarra, P Agarwal, L Ferrer, M Czader, U Dave Blood 136, 24, 2020 | 1 | 2020 |
| Real-world treatment patterns and outcomes in chronic lymphocytic leukemia (CLL) patients on novel agents in the US Veterans Health Administration (VHA) system: preliminary … Z Nooruddin, H Le, D McHugh, C Elesinmogun, S Galley, K Franklin, ... LEUKEMIA & LYMPHOMA 61, 61-63, 2020 | 1 | 2020 |
| Mycobacterium Tuberculosis infection in Patients with Hematologic Malignancies in an Endemic Setting: An Initial Analysis MR Espinoza-Gutarra, CA Saavedra-Ramirez, FK Llanos-Tejada, ... Blood 130, 5658, 2017 | 1 | 2017 |
| Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia K Diebold, G Bourne, M Espinoza-Gutarra, Z Al-Kadhimi, K Bachiashvili, ... Leukemia & Lymphoma, 1-3, 2024 | | 2024 |
| Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies K Parks, K Diebold, D Salzman, A Di Stasi, Z Al‐Kadhimi, ... EJHaem, 2024 | | 2024 |
| Radiation-free conditioning in acute lymphoblastic leukemia: is it time? M Espinoza-Gutarra, R Mohty, O Jamy Chinese Clinical Oncology 13 (2), 29-29, 2024 | | 2024 |
| The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA) A Ta, S Kaur, M Mader, K Franklin, M Williams, R Williams, JP Blaize, ... Leukemia & Lymphoma, 1-10, 2024 | | 2024 |
| Factors Associated with Cancer Prevention/Risk Reduction Behaviors among Latinos SM Rawl, G Maupome, L Golzarri-Arroyo, E Parker, HA O’Leary, ... Journal of Racial and Ethnic Health Disparities, 1-13, 2023 | | 2023 |
